Skip to main content

Schonfeld Strategic Advisors LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1665241 NEW YORK, NY

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,519,961
+$800,662 QoQ
Shares Held
318,177
+7.3% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#56
of 238 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $64,099,635 across 21 Drug Manufacturers - Specialty & Generic names. XERS ranks #10 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,519,961 318,177
2026-03-31 $1,719,299 296,431
2025-12-31 $1,842,575 234,723
2025-09-30 $2,478,662 304,504
2025-06-30 $1,816,938 389,066
2025-03-31 $3,294,916 600,167
2024-12-31 $349,170 103,000
2024-09-30 $491,131 172,327
2024-06-30 $756,105 336,047
2024-03-31 $642,000 290,498
2023-06-30 $67,596 25,800
2022-03-31 $32,000 12,500